InsidersTradesSigma
Browse the detailed record of transactions filed by Mehalick David, Chairman & CEO. Director active across 1 companies, notably Coeptis Therapeutics Inc.. Cumulatively, 2 reports have been published. Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
David Mehalick is the CEO and President of Coeptis Therapeutics Inc. As the leader of the company, he is responsible for setting the strategic vision and overseeing daily operations. His role is crucial in guiding the company within the biotechnology sector, ensuring innovation and growth.